Suchergebnisse - "Portman, David"

PubPharm (94)

61

Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill

enthalten in: Contraception | 2015

von Kaunitz, A. | Portman, D. | Westhoff, C. | +3

62

Genitourinary syndrome of menopause : new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society

enthalten in: The journal of sexual medicine | 2014

von Portman, D. | Gass, M. | Vulvovaginal Atrophy Terminology Consensus Conference Panel | +20

63

Genitourinary syndrome of menopause : new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society

enthalten in: Menopause (New York, N.Y.) | 2014

von Portman, D. | Gass, M. | Vulvovaginal Atrophy Terminology Consensus Conference Panel | +20

64

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause

enthalten in: Menopause (New York, N.Y.) | 2014

von Portman, D. | Kaunitz, A. | Kazempour, K. | +3

CommentIn: Climacteric. 2014 Jun;17(3):313-4. - PMID 24945035

65

Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause

enthalten in: Menopause (New York, N.Y.) | 2014

von Pinkerton, J. | Kagan, R. | Portman, D. | +3

CommentIn: Menopause. 2014 Jun;21(6):551-2. - PMID 24781852

66

enthalten in: Obstetrics and gynecology | 2014

von Kaunitz, A. | Portman, D. | Westhoff, C. | +3

CommentOn: Obstet Gynecol. 2014 Feb;123(2 Pt 1):295-303. - PMID 24402597

67

Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive

enthalten in: Contraception | 2014

von Portman, D. | Kaunitz, A. | Howard, B. | +3

68

Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive

enthalten in: Contraception | 2014

von Portman, D. | Kaunitz, A. | Howard, B. | +3

69

Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women

enthalten in: Maturitas | 2014

von Simon, J. | Portman, D. | Mabey, R. | +65

70

Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women

enthalten in: Maturitas | 2014

von Simon, J. | Portman, D. | Mabey, R.